Improving treatment of chromoblastomycosis: the potential of COP1T-HA and antimicrobial photodynamic therapy against <i>Fonsecaea monophora in vitro</i>.

ABSTRACT: Fonsecaea monophora is one of the common pathogenic species of Chromoblastomycosis (CBM). Antimicrobial photodynamic therapy (aPDT) shows promise as a new treatment for CBM. In this study, we evaluated the effectiveness of COP1T-HA which is a porous organic cage and aPDT against Fonsecaea spp. in vitro.

SUBMITTER: Liu X 

PROVIDER: S-EPMC11899202 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature